AzTrials
AzTrials

AcupunctureNCT05535985

Study of Acupuncture on Postoperative Delirium in Patients With Diabetes Mellitus

A study testing acupuncture in people with Acupuncture and Postoperative Delirium (POD), run by Lingling Ding.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. To evaluate the effectiveness and safety of acupuncture on POD in diabetic patients undergoing surgery, to provide effective prevention and treatment measures of integrated traditional Chinese and western medicine for reducing the incidence of postoperative delirium in high-risk groups, and to provide clinical… Read more about this study

Who is it for?
Ages 30 to 80 years
What is being tested?
acupuncture
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
215 participants
Where
No sites listed yet
Study dates
1 Jan 2023to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing general anesthesia in our hospital
  • Expected duration of operation >2h
  • Ages 18-60
  • With type 2 diabetes
  • American Society of Anesthesiologists (ASA) grade 2-3 , no severe respiratory, circulation, liver, kidney, coagulation function abnormalities;
  • Expected postoperative hospital stay >3 days
  • No history of cerebrovascular accident in the past six months
  • The informed consent signed

Who cannot join

  • Unable or unwilling to cooperate with cognitive function scale tests
  • MMSE score <24
  • Refuse acupuncture treatment or have a history of needle sickness
  • With skin damage at the acupuncture sites
  • Coagulation dysfunction
  • Participated in other clinical studies

Trial locations and contacts

No sites are listed yet.

Lingling Ding, Doctor contact

+86 010 87906647

dinglingling301@126.com

Ruiling Zhou, Master contact

+86 010 87906647

1652282940@qq.com

About this study

Official title: A Prospective Randomized Controlled Study of Acupuncture on Postoperative Delirium in Patients With Diabetes Mellitus

  1. To evaluate the effectiveness and safety of acupuncture on POD in diabetic patients undergoing surgery, to provide effective prevention and treatment measures of integrated traditional Chinese and western medicine for reducing the incidence of postoperative delirium in high-risk groups, and to provide clinical basis for further promotion of integrated traditional Chinese and western medicine anesthesia in the future.
  2. To investigate the relationship between POD and rSO2 in diabetic patients undergoing surgery. To clarify the predictive value of intraoperative rSO2 monitoring on postoperative cognitive function in patients with diabetes, and to explore the effect of acupuncture on cerebral blood flow perfusion in patients with diabetes.
Read the detailed description

Postoperative delirium (POD) increases the risk of postoperative dementia and mortality. Cognitive decline is common in patients with diabetes mellitus. As an independent risk factor for POD, diabetes significantly increases postoperative dementia and mortality. Our team found that acupuncture can reduce the incidence of POD in elderly patients, increase regional cerebral oxygen saturation (rSO2), and increase cerebral blood flow perfusion in diabetic patients. In this study, a prospective randomized controlled study with placebo acupuncture will be conducted. Diabetic patients undergoing elective surgery will be divided into acupuncture group, placebo acupuncture group and control group. Acupuncture will be used as the intervention method, and the incidence of POD will be the main therapeutic effect evaluation index to explore the efficacy of acupuncture in the prevention and treatment of POD in diabetic patients undergoing surgery.

Being tested
acupuncture, placebo acupuncture
Keywords
Acupuncture, Postoperative delirium (POD), Diabetes Mellitus, Regional Cerebral Oxygen Saturation (rSO2)
Medical subject headings
Emergence Delirium, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • acupunctureDevice

    treatment of pain or disease by inserting the tips of needles at specific points on the skin

  • placebo acupunctureDevice

    placebo acupuncture

Study groups in NCT05535985
Study groupRoleWhat they receive
acupuncture groupExperimentalIn the acupuncture group, acupoints of Baihui, Shenting, Sishencong will be selected for acupuncture stimulation be anesthesia. The needle will be kept for 30 minutes, during which the needle will be performed once every 10 minutes for 10 seconds each time, 4 times in total. The therapist will give the subject verbal cues before and during the needle manipulation.
Receives: Device: acupuncture
placebo acupuncture groupPlacebo comparatorThe patients will be treated with consolation needle. Choose treatment of points that near but without going through the acupoints(upper arm deltoid muscle). Use the Park needle (blunt needle, tip obtuse, when acupuncture the feeling is similar to acupuncture needles into the skin, but it retracts instead of piercing the skin) to conduct acupuncture treatment. The retention time and number of needles will be the same as those in the acupuncture group. The therapist will give the subjects verbal cues before and during the acupuncture manipulation, which further reduces the subjects' doubts about the authenticity of acupuncture in the this group. To ensure the implementation of the blinding method, all patients will be treated independently and avoid contacting with each other.
Receives: Device: placebo acupuncture
control groupNo interventionThe patients will undergoing routine anesthesia without acupuncture treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using the 3-minute diagnostic confusion assessment method (3D-CAM)

    Measured: at 8 a.m. the day after surgery

  2. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Measured: at 16 p.m. the day after surgery

  3. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Measured: at 8 a.m. the second day after surgery

  4. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Measured: at 16 p.m. the second day after surgery

  5. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Measured: at 8 a.m. the third day after surgery

  6. Incidence of postoperative delirium

    assess the incidence of postoperative delirium using 3D-CAM

    Measured: at 16 p.m. the third day after surgery

Secondary outcomes (10)
  1. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes.

    rSO2 values of each time point, maximum and minimum values during surgery.

    Measured: baseline

  2. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes.

    rSO2 values of each time point, maximum and minimum values during surgery.

    Measured: the time when tracheal intubation finished

  3. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes.

    rSO2 values of each time point, maximum and minimum values during surgery.

    Measured: the time when the surgery begins

  4. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes.

    rSO2 values of each time point, maximum and minimum values during surgery.

    Measured: 1 hour after the beginning of the surgery

  5. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes.

    rSO2 values of each time point, maximum and minimum values during surgery.

    Measured: the time when the surgery ends

  6. Regional Saturation of Oxygenation (rSO2)

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes.

    rSO2 values of each time point, maximum and minimum values during surgery.

    Measured: Intraoperative

  7. Visual Analogue Score (VAS)

    Record VAS. VAS is a psychometric response score. Draw a 10 cm horizontal line on the paper. The end of the line is 0, indicating no pain; the other end is 10, indicating severe pain. The middle part shows different levels of pain.

    Measured: at 8 a.m. and 16 p.m. daily for 3 days after surgery

  8. Blood glucose levels

    record blood glucose levels

    Measured: Entering the operating room, the time when the surgery ends

  9. Expression of reactive oxygen species (ROS), superoxide dismutase (SOD), S100β in serum

    The inflammation level will be assessed.

    Measured: Entering the operating room, the time when the surgery ends

  10. Expression of peroxisome proliferators-activated receptor-γcoactivator-1α (PGC-1α)

    assess the expression of PGC-1α

    Measured: Entering the operating room, the time when the surgery ends

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2022
  2. Study start1 Jan 2023 (estimated)
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
215 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05535985
Sponsor's protocol ID
SHOUFA 2022-2-2232
Status last verified
Sep 2022
First submitted
1 Sep 2022
Last updated
14 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing acupuncture in people with Acupuncture and Postoperative Delirium (POD), run by Lingling Ding.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lingling Ding, Doctor (+86 010 87906647, dinglingling301@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative delirium (time frame: at 8 a.m. the day after surgery). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in